Trv Gp Iv, LLC Tango Therapeutics, Inc. Transaction History
Trv Gp Iv, LLC
- $80.2 Million
- Q4 2024
A detailed history of Trv Gp Iv, LLC transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Trv Gp Iv, LLC holds 16,859,075 shares of TNGX stock, worth $40.6 Million. This represents 64.97% of its overall portfolio holdings.
Number of Shares
16,859,075
Previous 16,859,075
-0.0%
Holding current value
$40.6 Million
Previous $130 Million
59.87%
% of portfolio
64.97%
Previous 80.09%
Shares
3 transactions
Others Institutions Holding TNGX
# of Institutions
138Shares Held
91.1MCall Options Held
1.4KPut Options Held
4.4K-
Tcg Crossover Management, LLC Palo Alto, CA10.7MShares$25.9 Million5.42% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA10.6MShares$25.6 Million1.53% of portfolio
-
Nextech Invest Ag5.53MShares$13.3 Million3.19% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4MShares$9.64 Million0.07% of portfolio
-
Black Rock Inc. New York, NY3.99MShares$9.61 Million0.0% of portfolio
About Tango Therapeutics, Inc.
- Ticker TNGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 88,067,296
- Market Cap $212M
- Description
- Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...